Anti Radiation Drugs Market is Estimated To Witness High Growth Owing To Increasing Prevalence of Cancer

 

Anti Radiation Drugs Market

The global Anti Radiation Drugs Market is estimated to be valued at US$ 587.4 Mn in 2023 and is expected to exhibit a CAGR of 6.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

 

Market Overview: Anti radiation drugs are used to protect healthy cells from the damaging effects of radiation exposure during cancer treatment, accidents or terrorist attacks using radioactive materials. These drugs reduce the side effects of radiation therapy such as nausea, vomiting and skin irritation.

 

Market key trends: One of the key trends fueling the growth of the anti radiation drugs market is the increasing adoption of artificial intelligence in radiation oncology. AI is increasingly being used to improve diagnosis and treatment planning, reduce side effects of radiation therapy and forecast patient outcomes. For instance, AI algorithms can be trained on huge datasets of prior treatments to predict which patients are most likely to develop side effects from radiation and require protective medication. This enables more personalized treatment approaches and promotes the preventive use of anti radiation drugs. Furthermore, AI assisted image guidance during radiation therapy allows real time monitoring and dose adjustments to minimize unintended exposure of healthy tissues, reducing the need for such protective drugs.

Segment Analysis

The global anti radiation drugs market is segmented by type, application, end user and region. Based on type, the anti radiation drugs market is segmented into radiation protection drugs, anticancer drugs and others. The anticancer drugs segment dominated the market in 2022 and is expected to continue its dominance over the forecast period due to rising prevalence of cancer and increasing adoption of anticancer drugs for radiation cancer treatment.

 

Key Takeaways

The Global Anti Radiation Drugs Market Size is expected to witness high growth, exhibiting CAGR of 6.8% over the forecast period, due to increasing prevalence of cancer and growing awareness about radiation protection.

 

The global anti radiation drugs market size is expected to reach US$ 587.4 Mn in 2023.

 

North America is expected to dominate the anti radiation drugs market during the forecast period. This is attributed to growing geriatric population, rising cancer incidence and increasing initiatives by governments and cancer associations to spread awareness about cancer prevention and treatment in the region.

 

Key players operating in the anti radiation drugs market are RxBio Inc., Annova Chem Inc., Medicom Healthcare Ltd., Onconova Therapeutics, Genome Protection Inc., Grace Therapeutics LLC, Amgen Inc., Partner Therapeutics Inc., Jubilant Life Sciences Ltd., Cipla Inc., Stium Inc., Soligenix Inc., Aeolus Pharmaceuticals, PharmaIN Corp, and Immune Modulators Inc.

Read more

https://www.dailyprbulletin.com/anti-radiation-drugs-market-size-share-growth-outlook-2023/

Comments

Post a Comment

Popular posts from this blog

"Global Heparin Market: Current Trends and Future Prospects"

Image
  Heparin, a crucial anticoagulant, has been a mainstay in the pharmaceutical industry for many years. It plays a pivotal role in preventing and treating conditions such as deep vein thrombosis, pulmonary embolism, and various cardiovascular diseases. As we delve into the current state of the heparin market, we will explore the trends, challenges, and opportunities that shape this vital segment of the pharmaceutical industry. Market Overview: The global heparin market has experienced steady growth over the years, driven by an aging population, increasing cases of cardiovascular diseases, and a rising awareness of the importance of anticoagulants in healthcare. Heparin is available in various forms, including unfractionated heparin (UFH) and low molecular weight heparin (LMWH), each with its own set of applications and market dynamics. Trends: 1.      Rising Demand for LMWH : Low molecular weight heparin is gaining popularity due to its ease of administr...
Read more

"Advancements in Cystic Fibrosis Treatment: A Comprehensive Market Analysis"

Image
  The cystic fibrosis market has seen significant advancements and changes in recent years. Cystic fibrosis is a genetic disorder that affects the lungs and digestive system, leading to thick and sticky mucus production that can cause serious respiratory and digestive complications. The introduction of new therapies and treatments, such as CFTR modulators, has revolutionized the management of cystic fibrosis, offering hope and improved quality of life for patients. These drugs target the underlying genetic mutations responsible for the condition, helping to alleviate symptoms and slow disease progression. However, challenges remain in the cystic fibrosis market . Access to these ground-breaking therapies can be limited due to high costs, and ongoing research is needed to develop treatments for all genetic mutations associated with the disease. Additionally, the market continues to evolve as new therapies and innovations emerge. Collaborative efforts between pharmaceutical compani...
Read more

Botanical Packaging is Estimated to Witness High Growth Owing to Growing Environmental Concerns

Image
  Botanical Packaging Market Botanical packaging involves using various plant-based materials like corn starch, wheat starch, soy protein, bamboo, bagasse as raw materials for manufacturing boxes, cartons, bags and wrapping films for packaging applications. These biodegradable materials offer attractive sustainability advantages over traditional petroleum-based plastics. Botanical packaging finds widespread application in food, beverage, pharmaceutical, personal care and homecare industries for primary, secondary and tertiary packaging needs. The global botanical packaging Market is estimated to be valued at US$ 138.24 Bn in 2023 and is expected to exhibit a CAGR of 34% over the forecast period 2024 to 2031.   Market Dynamics: Growing environmental concerns about the menace of plastic pollution have been fuelling adoption of sustainable packaging alternatives globally. One of the key drivers for botanical packaging market is the stringent government policies and regulati...
Read more